Aqemia
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $62M
Investors
- 4
About Aqemia
Based in Paris, France, and founded in 2019 by co-founders Maximilien Levesque (CEO) and Emmanuelle Martiano, Aqemia operates as a pharmatech company that develops an AI-based drug discovery platform that analyzes drug candidates and therapeutic targets for critical diseases. The company provides a wide range of drug discovery services, such as a proprietary therapeutic pipeline, genAI powered by physics, and quantum-inspired physics technology. Additionally, the firm also provides AI-enabled drug discovery solutions.
Who invested in Aqemia
4 investors across 2 rounds
See all investors in Aqemia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aqemia
Who invested in Aqemia?
Aqemia has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aqemia raised?
Aqemia has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aqemia last raise money?
Aqemia's most recent round on record is a Series A, in Jan 2024.
What does Aqemia do?
Based in Paris, France, and founded in 2019 by co-founders Maximilien Levesque (CEO) and Emmanuelle Martiano, Aqemia operates as a pharmatech company that develops an AI-based drug discovery platform that analyzes drug candidates and therapeutic targets for critical diseases.
Where is Aqemia headquartered?
Aqemia is headquartered in Paris, France.
Which VCs invest in companies like Aqemia?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Aqemia's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Aqemia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.